India to Chile: Ibrutinib Export Trade Route

The India to Chile Ibrutinib corridor is one of India's established pharmaceutical export routes, with 34 shipments documented worth a combined $27.6K USD. The route is dominated by JPC GLOBAL, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $810 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 23.5%, placing it at rank #10 among India's top ibrutinib export destinations globally.

On the import side, key buyers of Indian ibrutinib in Chile include THE PURCHASE MANAGER, TO THE, IMPORTING DEPARTMENT, IMPORTING DEPARTMENT IN CHIL E IMPORTADORA IMSIPHARMA SPA and 9 others. THE PURCHASE MANAGER is the single largest importer with 13 shipments valued at $9.4K USD.

India's ibrutinib exports to Chile are driven primarily by a handful of large-scale manufacturers. JPC GLOBAL with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in Chile benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — JPC GLOBAL, KALINDI OVERSEAS, KALINDI OVERSEAS — together account for 84% of total trade value on this route. The average shipment value of $810 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless pharmaceutical finished product- ibrutinib caps 140mg batch no. 502256,pcs30s and harmless pharmaceutical finished product- ibrutinib caps 140mg - pcs(30s), suggesting that buyers in Chile tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, THE PURCHASE MANAGER is the largest importer with 13 shipments worth $9.4K USD — representing 34% of all ibrutinib imports from India on this route. A total of 12 buyers are active on this corridor.